<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />


<meta name="date" content="2025-02-21" />

<title>Introduction</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>






<style type="text/css">

div.csl-bib-body { }
div.csl-entry {
clear: both;
margin-bottom: 0em;
}
.hanging div.csl-entry {
margin-left:2em;
text-indent:-2em;
}
div.csl-left-margin {
min-width:2em;
float:left;
}
div.csl-right-inline {
margin-left:2em;
padding-left:1em;
}
div.csl-indent {
margin-left: 2em;
}
</style>

<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Introduction</h1>
<h4 class="date">2025-02-21</h4>



<div id="introduction" class="section level1">
<h1>Introduction</h1>
<p>Health technology assessments and appraisals necessitate dependable
estimations of relative treatment effects to guide reimbursement
determinations. In instances where direct comparative evidence is
lacking, yet both treatments under scrutiny have been separately
evaluated against a shared comparator (e.g., placebo or standard care),
a conventional indirect comparison can be conducted utilizing published
aggregate data from each study.</p>
<p>This document outlines the procedures for conducting a
matching-adjusted indirect comparison (MAIC) analysis. MAIC is suitable
when individual patient data from one trial and aggregate data from
another are accessible. The analysis focuses on endpoints such as
time-to-event (e.g., overall survival) or binary outcomes (e.g.,
objective tumor response).</p>
<p>The methodologies detailed herein are based on the original work by
Signorovitch et al. (2010) and further elucidated in the National
Institute for Health and Care Excellence (NICE) Decision Support Unit
(DSU) Technical Support Document (TSD) 18. <span class="citation">[1,2]</span></p>
<p>A clinical trial lacking a common comparator treatment to link it
with other trials is termed an unanchored MAIC. Without a common
comparator, it becomes challenging to directly compare the outcomes of
interest between different treatments or interventions. Conversely, if a
common comparator is available, it is termed an anchored MAIC. An
anchored indirect comparison is preferred as it respects the
randomization within studies and removes confounding bias.</p>
<p>MAIC methods aim to adjust for between-study differences in patient
demographics or disease characteristics at baseline. In scenarios where
a common treatment comparator is absent, MAIC assumes that observed
differences in absolute outcomes between trials are solely attributable
to imbalances in prognostic variables and effect modifiers. This
assumption requires that all imbalanced prognostic variables and effect
modifiers between the studies are known, which is often challenging to
fulfill. <span class="citation">[2]</span></p>
<p>Various approaches exist for identifying prognostic variables and
effect modifiers for use in MAIC analyses. These include clinical
consultation with experts, review of published literature, examination
of previous regulatory submissions, and data-driven methods such as
regression modeling and subgroup analysis to uncover interactions
between baseline characteristics and treatment effects.</p>
</div>
<div id="statistical-theory-behind-maic" class="section level1">
<h1>Statistical theory behind MAIC</h1>
<p>The matching is accomplished by re-weighting patients in the study
with the individual patient data (IPD) by their odds of having been
enrolled in the aggregate data (AGD) study versus the IPD study. The
approach is very similar to inverse probability of treatment weighting
with the difference that IPD is not available for one study, so the
usual maximum likelihood approach cannot be used to estimate the
parameters. Instead, a method of moments is used. After the matching is
complete and weights have been added to the IPD, it is possible to
estimate the weighted outcomes and compare the results across.</p>
<p>The mapping approach can be described as follows: assuming that each
trial has one arm, each patient can be characterized by the following
random triple (<span class="math inline">\(X\)</span>, <span class="math inline">\(T\)</span>, <span class="math inline">\(Y\)</span>), where <span class="math inline">\(X\)</span> represents the baseline characteristics
(e.g., age and weight), <span class="math inline">\(T\)</span>
represents the treatment of interest (e.g., <span class="math inline">\(T = A\)</span> for the IPD study and <span class="math inline">\(T = B\)</span> for the study with AGD), and <span class="math inline">\(Y\)</span> is the outcome of interest (e.g.,
overall survival).</p>
<p>Each patient is characterized by a random triple (<span class="math inline">\(x_i\)</span>, <span class="math inline">\(t_i\)</span>, <span class="math inline">\(y_i\)</span>) with <span class="math inline">\(i=1\)</span> to <span class="math inline">\(n\)</span> but only when IPD is available, i.e.,
when <span class="math inline">\(t_i = A\)</span>. In case where <span class="math inline">\(t_i = B\)</span>, only the mean baseline
characteristics <span class="math inline">\(\bar{x}_{agg}\)</span> and
mean outcome <span class="math inline">\(\bar{y}_{agg}\)</span> are
observed.</p>
<p>Given the observed data, the causal effect of treatment <span class="math inline">\(T = A\)</span> versus <span class="math inline">\(T = B\)</span> on the mean of <span class="math inline">\(Y\)</span> can be estimated as follows:</p>
<p><span class="math display">\[
\frac{\sum_{i=1}^{n}y_{i}w_{i}}{\sum_{i=1}^{n}w_{i}}-\bar{y}_{agg}
\]</span></p>
<p>where <span class="math inline">\(w_i=\frac{Pr(T_i=B\mid
x_i)}{Pr(T_i=A\mid x_i)}\)</span>. Thus, the patients receiving <span class="math inline">\(T=A\)</span> are re-weighted to match the
distribution of patients receiving <span class="math inline">\(T=B\)</span>. Note that this causal effect would
be the case when the outcome <span class="math inline">\(Y\)</span> is
continuous. If the outcome is binary, <span class="math inline">\(Y\)</span> would be a proportion and we would use
a link function such as logit to give us the causal effect in an odds
ratio scale. We assume <span class="math inline">\(w_i\)</span> to
follow logistic regression form.</p>
<p><span class="math display">\[
w_{i}=exp(x_i^{T}\beta)
\]</span></p>
<p>In order to estimate <span class="math inline">\(\beta\)</span>, we
use method of moments. We estimate <span class="math inline">\(\beta\)</span> such that the weighted averages of
the covariates in the IPD exactly matches the aggregate data averages.
Mathematically speaking, we estimate <span class="math inline">\(\beta\)</span> such that:</p>
<p><span class="math display">\[
0=\frac{\sum_{i=1}^{n}x_{i}exp(x_i^{T}\hat{\beta})}{\sum_{i=1}^{n}exp(x_i^{T}\hat{\beta})}-\bar{x}_{agg}
\]</span></p>
<p>This equation is equivalent to</p>
<p><span class="math display">\[
0=\sum_{i=1}^{n}(x_{i}-\bar{x}_{agg})exp(x_{i}^{T}\hat{\beta})
\]</span></p>
<p>It is possible to use this estimator since a logistic regression
model for the odds of receiving <span class="math inline">\(T =
B\)</span> vs <span class="math inline">\(T = A\)</span> would, by
definition, provide the correct weights for balancing the trial
populations. If the <span class="math inline">\(x_i\)</span> contains
all the confounders and the logistic model for <span class="math inline">\(w_i\)</span> is correctly specified, then <span class="math inline">\(\hat{\theta}\)</span> in the next equation
provides a consistent estimate of the causal effect of treatment <span class="math inline">\(T = A\)</span> vs <span class="math inline">\(T =
B\)</span> on the mean of <span class="math inline">\(Y\)</span> among
patients.</p>
<p><span class="math display">\[
\hat{\theta}=\frac{\sum_{i=1}^{n}y_{i}exp(x_i^{T}\hat{\beta})}{\sum_{i=1}^{n}exp(x_i^{T}\hat{\beta})}-\bar{y}_{agg}
\]</span></p>
<p>In order to solve the equation set up by the methods of moments, we
could transform IPD by subtracting the aggregate data means. Then <span class="math inline">\(\bar{x}_{agg}\)</span> would equal 0 and the
equation would simplify. This is why IPD is centered in the
preprocessing step.</p>
<p><span class="math display">\[
0=\sum_{i=1}^{n}x_{i}exp(x_{i}^{T}\hat{\beta})
\]</span></p>
<p>Note that this is the first derivative of</p>
<p><span class="math display">\[
Q(\beta)=\sum_{i=1}^{n}exp(x_{i}^{T}\hat{\beta})
\]</span></p>
<p>which has second derivative</p>
<p><span class="math display">\[
Q&#39;&#39;(\beta)=\sum_{i=1}^{n}x_ix_i^Texp(x_{i}^{T}\hat{\beta})
\]</span></p>
<p>Since <span class="math inline">\(Q&#39;&#39;(\beta)\)</span> is
positive-definite for all <span class="math inline">\(\beta\)</span>,
<span class="math inline">\(Q(\beta)\)</span> is convex and any finite
solution from the equation is unique and corresponds to the global
minimum of <span class="math inline">\(Q(\beta)\)</span>. Thus, we can
use optimization methods to calculate <span class="math inline">\(\beta\)</span>.</p>
</div>
<div id="references" class="section level1 unnumbered">
<h1 class="unnumbered">References</h1>
<div id="refs" class="references csl-bib-body" entry-spacing="0">
<div id="ref-signorovitch2010" class="csl-entry">
<div class="csl-left-margin">[1] </div><div class="csl-right-inline">Signorovitch JE, Sikirica V, Erder MH, Xie J,
Lu M, Hodgkins PS, et al. Comparative effectiveness without head-to-head
trials. Pharmacoeconomics 2010;28:935–45.</div>
</div>
<div id="ref-phillippo2016a" class="csl-entry">
<div class="csl-left-margin">[2] </div><div class="csl-right-inline">Phillippo D, Ades T, Dias S, Palmer S, Abrams
KR, Welton N. NICE DSU technical support document 18: Methods for
population-adjusted indirect comparisons in submissions to NICE
2016.</div>
</div>
</div>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
